WideCells team details significant first contract for new Iconic Labs business
WideCells Group PLC’s (LON:WDC) David Sefton and John Quinlan tell Proactive London’s Andrew Scott they’re expecting to book initial revenues in the first year from the deal of more than £1mln and the contract, currently agreed in principle, offers the potential for material increases.
It’s with a UK-based financial services business on a long-term retainer basis.
Sefton adds that the completion of the restructuring is now very close and will be followed by an official proposal to change the company’s name to Iconic Labs PLC.
Source Link www.proactiveinvestors.co.uk/companies/stocktube
Article originally published by proactive investors. Share Talk is not responsible for its content or accuracy and may not share the author’s views. News and research are not personal recommendations to deal. All investments can fall in value so you could get back less than you invest.
